Autologous Tumor Cell Vaccination Combined With Systemic CpG-B and IFN-α Promotes Immune Activation and Induces Clinical Responses in Patients With Metastatic Renal Cell Carcinoma: A Phase II Trial
Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-019-02320-0
Full Text
Open PDFAbstract
Available in full text
Date
March 9, 2019
Authors
Publisher
Springer Science and Business Media LLC